HR 8540 United States House · 117th Congress

Developing and Nationalizing Key Cannabis Research Act of 2022

Summary

Developing and Nationalizing Key Cannabis Research Act of 2022 This bill directs the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to expand activities concerning cannabis research. The NIH must collaborate with specified agencies to develop a national cannabis research agenda. Among other topics, the agenda must address (1) the therapeutic benefits of cannabis, (2) how cannabis effects specified populations, and (3) other public safety considerations. Additionally, the NIH must designate centers of excellence in cannabis research at institutions of higher education to conduct interdisciplinary research about biomedical, behavioral, and social issues related to cannabis. The CDC must work with other agencies to collect population-wide data about cannabis use, including (1) demographic factors, (2) health outcomes, (3) product variety, and (4) other relevant health information.

Issues: ✓ Healthcare

Bill status in committee 1 of 4 stages cleared

Introduction

Jul 2022

Committee Review

Floor Vote

President

Introduced Jul 27, 2022 Last action Nov 1, 2022

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Nov 1, 2022

Committee

Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

lower

Jul 27, 2022

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Jul 27, 2022

Introduced

Introduced in House

lower

1 primary · 1 co-sponsor